|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Obalon Therapeutics (NASDAQ: OBLN) through any online brokerage.
The latest price target for Obalon Therapeutics (NASDAQ: OBLN) was reported by Canaccord Genuity on 2019-04-08. The analyst firm set a price target for 1.50 expecting OBLN to fall to within 12 months (a possible -46.04% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Obalon Therapeutics (NASDAQ: OBLN) is $2.78 last updated Fri Mar 05 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Obalon Therapeutics.
There is no upcoming split for Obalon Therapeutics.